Research Summary
An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.
According to DIResearch's in-depth investigation and research, the global siRNA Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc. etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of siRNA Drug Include:
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
siRNA Drug Product Segment Include:
Givlaari
Patisiran
Givosiran
siRNA Drug Product Application Include:
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global siRNA Drug Industry PESTEL Analysis
Chapter 3: Global siRNA Drug Industry Porter's Five Forces Analysis
Chapter 4: Global siRNA Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global siRNA Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 siRNA Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 siRNA Drug Product by Type 1.2.1 Global siRNA Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Givlaari 1.2.3 Patisiran 1.2.4 Givosiran 1.3 siRNA Drug Product by Application 1.3.1 Global siRNA Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Single Gene Rare Disease 1.3.3 Protein Deposition Disease 1.3.4 Chronic Liver Disease 1.3.5 Others 1.4 Global siRNA Drug Market Revenue and Sales Analysis 1.4.1 Global siRNA Drug Market Size Analysis (2019-2030) 1.4.2 Global siRNA Drug Market Sales Analysis (2019-2030) 1.4.3 Global siRNA Drug Market Sales Price Trend Analysis (2019-2030) 1.5 siRNA Drug Market Development Status and Trends 1.5.1 siRNA Drug Industry Development Status Analysis 1.5.2 siRNA Drug Industry Development Trends Analysis 2 siRNA Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 siRNA Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global siRNA Drug Market Analysis by Regions 4.1 siRNA Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global siRNA Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global siRNA Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global siRNA Drug Revenue Forecast by Region (2025-2030) 4.3 Global siRNA Drug Sales and Forecast Analysis (2019-2030) 4.3.1 Global siRNA Drug Sales and Market Share by Region (2019-2024) 4.3.2 Global siRNA Drug Sales Forecast by Region (2025-2030) 4.4 Global siRNA Drug Sales Price Trend Analysis (2019-2030) 5 Global siRNA Drug Market Size by Type and Application 5.1 Global siRNA Drug Market Size by Type 5.1.1 Global siRNA Drug Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global siRNA Drug Sales and Forecast Analysis by Type (2019-2030) 5.2 Global siRNA Drug Market Size by Application 5.2.1 Global siRNA Drug Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global siRNA Drug Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America siRNA Drug Market Size by Type 6.3.1 North America siRNA Drug Sales by Type (2019-2030) 6.3.2 North America siRNA Drug Revenue by Type (2019-2030) 6.4 North America siRNA Drug Market Size by Application 6.4.1 North America siRNA Drug Sales by Application (2019-2030) 6.4.2 North America siRNA Drug Revenue by Application (2019-2030) 6.5 North America siRNA Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe siRNA Drug Market Size by Type 7.3.1 Europe siRNA Drug Sales by Type (2019-2030) 7.3.2 Europe siRNA Drug Revenue by Type (2019-2030) 7.4 Europe siRNA Drug Market Size by Application 7.4.1 Europe siRNA Drug Sales by Application (2019-2030) 7.4.2 ? Europe siRNA Drug Revenue by Application (2019-2030) 7.5 Europe siRNA Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China siRNA Drug Market Size by Type 8.3.1 China siRNA Drug Sales by Type (2019-2030) 8.3.2 China siRNA Drug Revenue by Type (2019-2030) 8.4 China siRNA Drug Market Size by Application 8.4.1 China siRNA Drug Sales by Application (2019-2030) 8.4.2 China siRNA Drug Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) siRNA Drug Market Size by Type 9.3.1 APAC (excl. China) siRNA Drug Sales by Type (2019-2030) 9.3.2 APAC (excl. China) siRNA Drug Revenue by Type (2019-2030) 9.4 APAC (excl. China) siRNA Drug Market Size by Application 9.4.1 APAC (excl. China) siRNA Drug Sales by Application (2019-2030) 9.4.2 APAC (excl. China) siRNA Drug Revenue by Application (2019-2030) 9.5 APAC (excl. China) siRNA Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America siRNA Drug Market Size by Type 10.3.1 Latin America siRNA Drug Sales by Type (2019-2030) 10.3.2 Latin America siRNA Drug Revenue by Type (2019-2030) 10.4 Latin America siRNA Drug Market Size by Application 10.4.1 Latin America siRNA Drug Sales by Application (2019-2030) 10.4.2 Latin America siRNA Drug Revenue by Application (2019-2030) 10.5 Latin America siRNA Drug Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa siRNA Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa siRNA Drug Market Size by Type 11.3.1 Middle East & Africa siRNA Drug Sales by Type (2019-2030) 11.3.2 Middle East & Africa siRNA Drug Revenue by Type (2019-2030) 11.4 Middle East & Africa siRNA Drug Market Size by Application 11.4.1 Middle East & Africa siRNA Drug Sales by Application (2019-2030) 11.4.2 Middle East & Africa siRNA Drug Revenue by Application (2019-2030) 11.5 Middle East & Africa siRNA Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global siRNA Drug Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global siRNA Drug Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global siRNA Drug Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global siRNA Drug Average Sales Price by Manufacturers (2020-2024) 12.2 siRNA Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 siRNA Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Genzyme 13.1.1 Genzyme Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Genzyme siRNA Drug Product Portfolio 13.1.3 Genzyme siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Alnylam 13.2.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Alnylam siRNA Drug Product Portfolio 13.2.3 Alnylam siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Dicerna 13.3.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Dicerna siRNA Drug Product Portfolio 13.3.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Quark Pharmaceuticals 13.4.1 Quark Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Quark Pharmaceuticals siRNA Drug Product Portfolio 13.4.3 Quark Pharmaceuticals siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Arrowhead 13.5.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Arrowhead siRNA Drug Product Portfolio 13.5.3 Arrowhead siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Exicure 13.6.1 Exicure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Exicure siRNA Drug Product Portfolio 13.6.3 Exicure siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Miragen Therapeutics 13.7.1 Miragen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Miragen Therapeutics siRNA Drug Product Portfolio 13.7.3 Miragen Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Silence 13.8.1 Silence Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Silence siRNA Drug Product Portfolio 13.8.3 Silence siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Sylentis 13.9.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Sylentis siRNA Drug Product Portfolio 13.9.3 Sylentis siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Avidity Biosciences 13.10.1 Avidity Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Avidity Biosciences siRNA Drug Product Portfolio 13.10.3 Avidity Biosciences siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Dicerna 13.11.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Dicerna siRNA Drug Product Portfolio 13.11.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 BioNTech 13.12.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 BioNTech siRNA Drug Product Portfolio 13.12.3 BioNTech siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Moderna Therapeutics 13.13.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Moderna Therapeutics siRNA Drug Product Portfolio 13.13.3 Moderna Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.14 The WhiteOak Group, Inc. 13.14.1 The WhiteOak Group, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 The WhiteOak Group, Inc. siRNA Drug Product Portfolio 13.14.3 The WhiteOak Group, Inc. siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 siRNA Drug Industry Chain Analysis 14.2 siRNA Drug Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 siRNA Drug Typical Downstream Customers 14.4 siRNA Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support